Bevacizumab biosimilar BEVZ92 versus reference bevacizumab in combination with FOLFOX or FOLFIRI as first-line treatment for metastatic colorectal cancer: a multicentre, open-label, randomised controlled trial. (Record no. 28881195)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02397 a2200637 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250518001232.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201905s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 2468-1253 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1016/S2468-1253(18)30269-3 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Romera, Alvaro |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20190528 |
245 00 - TITLE STATEMENT | |
Title | Bevacizumab biosimilar BEVZ92 versus reference bevacizumab in combination with FOLFOX or FOLFIRI as first-line treatment for metastatic colorectal cancer: a multicentre, open-label, randomised controlled trial. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | The lancet. Gastroenterology & hepatology |
Date of publication, distribution, etc. | 12 2018 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 845-855 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies |
General subdivision | blood |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents, Immunological |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Area Under Curve |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Bevacizumab |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Biosimilar Pharmaceuticals |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Camptothecin |
General subdivision | analogs & derivatives |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Colorectal Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Fluorouracil |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Intention to Treat Analysis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Leucovorin |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoplasm Metastasis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Organoplatinum Compounds |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Progression-Free Survival |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Therapeutic Equivalency |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Peredpaya, Sergiy |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Shparyk, Yaroslav |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bondarenko, Igor |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mendonça Bariani, Giovanni |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Abdalla, Kathia Cristina |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Roca, Enrique |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Franke, Fábio |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Melo Cruz, Felipe |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ramesh, Anita |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ostwal, Vikas |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Shah, Pradeep |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rahuman, Sajeed Abdul |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Paravisini, Alexandra |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Huerga, Camino |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Del Campo García, Ana |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Millán, Susana |
773 0# - HOST ITEM ENTRY | |
Title | The lancet. Gastroenterology & hepatology |
Related parts | vol. 3 |
-- | no. 12 |
-- | p. 845-855 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1016/S2468-1253(18)30269-3">https://doi.org/10.1016/S2468-1253(18)30269-3</a> |
Public note | Available from publisher's website |
No items available.